Puma Biotechnology (PBYI) fell after a court ruled that some patents invalid in a patent dispute with with AstraZeneca over cancer drug.
https://seekingalpha.com/news/4139922-puma-biotechnology-drops-after-patents-ruled-invalid
Puma Biotechnology (PBYI) fell after a court ruled that some patents invalid in a patent dispute with with AstraZeneca over cancer drug.
https://seekingalpha.com/news/4139922-puma-biotechnology-drops-after-patents-ruled-invalid
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.